NYSE - Delayed Quote USD

Perrigo Company plc (PRGO)

Compare
24.38
-0.67
(-2.67%)
At close: January 10 at 4:00:02 PM EST
24.40
+0.02
+(0.08%)
After hours: January 10 at 6:17:49 PM EST

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Patrick Lockwood-Taylor President, CEO & Director 2.37M -- --
Mr. Eduardo Guarita Bezerra Executive VP & CFO 1.2M -- 1975
Mr. Ronald C. Janish Chief Transformation Officer and Executive VP of Global Operations & Supply Chain 1.36M -- 1966
Mr. Shannon Hukill Senior Director of Technical Operations -- -- --
Ms. Abbie Lennox EVP & Chief Scientific Officer -- -- --
Mr. Bradley Joseph Vice President of Global Investor Relations & Corporate Communications -- -- --
Mr. Charles Atkinson Executive VP, General Counsel & Secretary -- -- --
Ms. Mary Reilly-Brest Director of Global Organizational and Human Resource Development -- -- --
Mr. Robert Willis Chief Human Resources Officer & Executive VP -- -- 1969
Ms. Catherine C. B. Schmelter Executive VP and President of Consumer Self-Care Americas & Global Portfolio Optimization -- -- 1969

Perrigo Company plc

The Sharp Building
Hogan Place
Dublin, D02 TY74
Ireland
353 1 709 4000 https://www.perrigo.com
Sector: 
Healthcare
Full Time Employees: 
9,140

Description

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Corporate Governance

Perrigo Company plc’s ISS Governance QualityScore as of January 1, 2025 is 1. The pillar scores are Audit: 4; Board: 1; Shareholder Rights: 1; Compensation: 2.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 6, 2024 at 11:30 AM UTC

Perrigo Company plc Earnings Date

Recent Events

December 20, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 17, 2024 at 12:00 AM UTC

Dividend Date

November 29, 2024 at 12:00 AM UTC

Ex-Dividend Date

November 6, 2024 at 1:30 PM UTC

Q3 2024 Earnings Call

November 6, 2024 at 12:00 AM UTC

8-K/A: Corporate Changes & Voting Matters

September 17, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 9, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 2, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 30, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 10, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers